Today: 27 December 2025
Subscribe
Browse Category

Stock Market News 22 December 2025

Warner Bros. Discovery (WBD) Stock: Netflix Deal, Paramount Bid, and Key Numbers to Watch Before the Market Opens on Dec. 22, 2025

Warner Bros. Discovery (WBD) Stock: Netflix Deal, Paramount Bid, and Key Numbers to Watch Before the Market Opens on Dec. 22, 2025

Warner Bros. Discovery, Inc. – Series A (NASDAQ: WBD) heads into the Dec. 22, 2025 market open in an unusually binary spot: the stock is being pulled less by day-to-day operating performance and more by a fast-moving takeover battle that
22 December 2025
 ·  ·  ·  ·  ·  ·  · 
Qualcomm (QCOM) Stock: What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Earnings Forecasts, and Analyst Outlook

Qualcomm (QCOM) Stock: What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Earnings Forecasts, and Analyst Outlook

Qualcomm Incorporated (NASDAQ: QCOM) heads into the Dec. 22, 2025 market open with investors balancing two powerful narratives: a renewed push into data center AI and high-speed connectivity (now backed by a fresh acquisition), and persistent handset-related uncertainty tied to
22 December 2025
 ·  ·  ·  ·  · 
Goldman Sachs Stock (GS): What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Analyst Forecasts, and Key Catalysts

Goldman Sachs Stock (GS): What to Know Before the Market Opens on Dec. 22, 2025 — Latest News, Analyst Forecasts, and Key Catalysts

The Goldman Sachs Group, Inc. (NYSE: GS) enters the Dec. 22, 2025 session with momentum, a busy corporate-news backdrop, and a calendar shaped by a holiday‑shortened trading week. Shares most recently finished at $893.48 (Dec. 19 close), putting Goldman near
22 December 2025
 ·  ·  ·  ·  · 
AbbVie Stock (ABBV) Before the Market Opens on Dec. 22, 2025: Drug-Pricing Talks, Dividend Signals, and the Next Catalysts

AbbVie Stock (ABBV) Before the Market Opens on Dec. 22, 2025: Drug-Pricing Talks, Dividend Signals, and the Next Catalysts

AbbVie Inc. (NYSE: ABBV) heads into the Monday, December 22, 2025 U.S. market open with a familiar bull case—Skyrizi and Rinvoq continuing to replace lost Humira revenue—and a less familiar overhang: Washington’s accelerating push to reframe U.S. drug pricing through
22 December 2025
 ·  ·  ·  ·  · 
Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Alnylam Pharmaceuticals (ALNY) Stock: Nasdaq-100 Entry, Amvuttra Momentum, Analyst Targets and Key Risks to Know Before the Dec. 22, 2025 Market Open

Ahead of the U.S. stock market open on Monday, December 22, 2025, Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is stepping into a new spotlight—not just for biotech fundamentals, but also for a major index catalyst that can reshape short-term trading dynamics.
22 December 2025
 ·  ·  ·  ·  · 
1 … 109 110 111 112 113 … 914
Go toTop